EXHIBIT 24

LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS


Know all by these presents, that the undersigned hereby makes,

constitutes and appoints Steven Fruchtman and Mark Guerin as

the undersigned's true and lawful attorney-in-fact, with full power

and authority as hereinafter described on behalf of and in the name,

place and stead of the undersigned to:


  (1)  prepare, execute, acknowledge, deliver and file Forms 3, 4,

and 5 (as applicable, including any amendments thereto) with respect

to the securities of Onconova Therapeutics, Inc., a Delaware

corporation (the "Company"), with the United States Securities

and Exchange Commission, any national securities exchanges and

the Company, as considered necessary or advisable under Section

16(a) of the Securities Exchange Act of 1934 and the rules and

regulations promulgated thereunder, as amended from time to

time (the "Exchange Act");


  (2)  seek or obtain, as the undersigned's representative and

on the undersigned's behalf, information on transactions in the

Company's securities from any third party, including but not

limited to brokers, employee benefit plan administrators and

trustees, and the undersigned hereby authorizes any such third

party to release any such information to the undersigned and approves

and ratifies any such release of information to the undersigned; and


  (3)  perform any and all other acts which in the discretion

of such attorney-in-fact are necessary or desirable for and on behalf

of the undersigned in connection with the foregoing.


The undersigned acknowledges that:


  (1)  this Limited Power of Attorney authorizes, but does not

require, such attorney-in-fact to act in his discretion on

information provided to such attorney-in-fact without independent

verification of such information;


  (2)  any documents prepared and/or executed by such

attorney-in-fact on behalf of the undersigned pursuant to this

Limited Power of Attorney will be in such form and will contain

such information and disclosure as such attorney-in-fact,

in his discretion, deems necessary or desirable;


  (3)  neither the Company nor such attorney-in-fact assumes (i) any

 liability for the undersigned's responsibility to comply with the

requirements of the Exchange Act, (ii) any liability of the

undersigned for any failure to comply with such requirements, or

(iii) any obligation or liability of the undersigned for profit

disgorgement under Section 16(b) of the Exchange Act; and


  (4)  this Limited Power of Attorney does not relieve the undersigned

from responsibility for compliance with the undersigned's obligations

under the Exchange Act, including without limitation the reporting

requirements under Section 16 of the Exchange Act.


  The undersigned hereby gives and grants the foregoing attorney-in-fact




full power and authority to do and perform all and every act and thing

whatsoever requisite, necessary or appropriate to be done in and about

the foregoing matters as fully to all intents and purposes as the

undersigned might or could do if present, hereby ratifying all that

such attorney-in-fact of, for and on behalf of the undersigned, shall

lawfully do or cause to be done by virtue of this Limited Power of

Attorney.


  This Limited Power of Attorney shall remain in full force and effect

until revoked by the undersigned in a signed writing delivered to such

 attorney-in-fact.


  IN WITNESS WHEREOF, the undersigned has caused this Limited Power

of Attorney to be executed as of this 19th day of October, 2023.




/s/ VICTOR MOYO


Name: Victor Moyo





Onconova Therapeutics (NASDAQ:ONTX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Onconova Therapeutics Charts.
Onconova Therapeutics (NASDAQ:ONTX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Onconova Therapeutics Charts.